Euthymics Bioscience, a US-based developer of antidepressants, raises $24m from Novartis and venture capital firms to acquire DOV and develop drugs.

Compass EOS aims for $20m in latest round of funding from Cisco Systems and venture capital firms.

US entrepreneurs from minority backgrounds to gain funding vehicle if cable company Comcast's merger with broadcaster NBC Universal goes ahead.

IPierian joins Adimab as second public minority investment by search group's corporate venturing division.

Eight venture investors commit another $20m to Nereus a decade after its first round to take the total raised so far to nearly $150m.

Disney's corporate venturing division Steamboat Ventures backs $33m series A extension for social gaming company.

CMEA Capital and Kaiser Permanente Ventures join $30m funding for Baxano

Aquinox Pharmaceuticals brings in second corporate venturing unit to bolster its $25m series B round.

Predictive Biosciences gains $25m in third-round funding with repeat investors following ProQuest Investments.

Novo Ventures becomes second corporate venturing unit to back US-based FoldRx Pharmaceuticals.